Short description
Verastem is a biopharmaceutical company that focuses on discovering and developing novel drugs that selectively target cancer stem cells.
Description
Verastem Oncology is a biopharmaceutical company committed to the development and commercialization of medicines to improve the lives of patients diagnosed with cancer. Its portfolio consists of small molecule kinase inhibitors that inhibit critical signaling pathways, which promote cancer cell survival and tumor growth.
Last funding
Noaccess
Sign in for full access
Total funding
$$43214321
Sign in for full access
Location
Needham, Massachusetts, United States, North America
Founded on
January 1, 2010
Exited on
January 27, 2012
Went public on
January 27, 2012
Stock symbol
VSTM
Non-profit?
No
Acquired?
No
Employees count
101-250
Revenue range
$1230 - 4560
Sign in for full access
Investors
Blurry Noaccess, Noaccess, Noaccess, Uh Ohhhh, Noway Youcantaccess, Blurry Noaccess, Blurry Noaccess, Nopepepe, Blurry Noaccess
Sign in for full access
Founders
Michelle Dipp